INGN

Inogen Inc

Nasdaq· Orthopedic, Prosthetic & Surgical Appliances & Supplies· Inc. DE· CIK 0001294133 Healthcare & Medical Devices

$7.08 −0.02 (−0.28%)

Oct 26 4:00 PM ET · prev $7.10

Market cap

$186.8M

Micro cap

Median target

$12.00

+69% · range $12.00–12.00

Next earnings

Nov 5

in 9 days · EPS est. −$0.06

1 year

−18.2%

from $8.66 · Oct 27

30 days

+30.1%

from $5.44

52-week range

$5.09–8.66

−18% from high · low Sep 23

Avg volume 20D

323.7K

Oct 1 spike 1.10M

Short interest

🔒 Subscribers only

Insider net

−$142.5K

0 buyers · 1 seller · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read MIXED 3 reports · latest

Balance 0 bearish · 1 bullish · 2 neutral oldest → newest, height = score

Avg score

·High conf. 3/3 ·Next Earnings date, Nov 5, 2026

Strongest NEUTRAL Inogen shareholders approved the Amended and Restated 2023 Equity Incentive Plan at the annual meeting on…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Feb 24 Inogen reported full-year 2025 revenue growth of 3.9% to $348.7 mill…
R Apr 6 Inogen Inc. has entered into a cooperation agreement with activist i…
A Apr 7 Freedom Broker initiates
S May 29 1 insider sell $70.3K at $6.53
S Jul 1 1 insider sell $72.1K at $6.60

Signal stack

Where each data set points today.

InsidersBEARISH

1 insider sold $142.5K.
InstitutionsBULLISH

Q2 2026: 21 added (0 new), 8 trimmed or exited.
TrendUPTREND

24% above its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	ADD	743,252	$4.8M
JACOBS LEVY EQUITY MANAGEMENT, INC	ADD	388,788	$2.5M
UBS Group AG	ADD	301,596	$1.9M
Nuveen, LLC	TRIM	185,572	$1.2M
Point72 Asset Management, L.P.	TRIM	171,342	$1.1M
Quantinno Capital Management LP	ADD	132,727	$856.1K
Assenagon Asset Management S.A.	ADD	86,940	$560.8K
IEQ CAPITAL, LLC	DOUBLED	73,589	$474.6K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Apr 2026

12-month targets · 2 analysts

$7.08 $12.00 $12.00 $12.00

Price is below the lowest target. Median implies +69%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Apr 7, 2026	Freedom Broker INITIATE	INITIATE	Buy
Jun 16, 2025	B. Riley Securities INITIATE	INITIATE	Buy
May 22, 2025	Needham UPGRADE	UPGRADE	Buy
May 8, 2025	Stifel MAINTAIN	MAINTAIN	Hold
Apr 9, 2025	Needham REITERATE	REITERATE	Hold
Feb 27, 2025	Needham REITERATE	REITERATE	Hold

Insider ledger

Form 4

bought · 0 insiders

$142.5K

sold · 1 insider

Date	Insider	Type	Value
Sep 1, 2026	Smith Kevin P. EVP, Bus Dev, GC & Sec	EXERCISE	18,136 sh
Sep 1, 2026	Wright Mary E VP, Chief Accounting Officer	AWARD	$8.0K
Sep 1, 2026	Smith Kevin P. EVP, Bus Dev, GC & Sec	TAX W/H	$46.2K
Sep 1, 2026	Smith Kevin P. EVP, Bus Dev, GC & Sec	AWARD	$8.0K
Sep 1, 2026	Smith Kevin Raymond Merrill CEO and President	AWARD	$8.0K
Jul 6, 2026	Reding Andrew P. EVP, COO	AWARD	130,000 sh
Jul 1, 2026	Yi Boyer Jennifer M EVP Entrprs Enblmnt, Ch HR Off	SELL	$72.1K
Jun 5, 2026	Ladone Mary Kay Director	AWARD	28,081 sh

Earnings setup

Estimates

Nov 5

reports in 9 days

−$0.06

EPS estimate, this quarter

0↑ 1↓

revisions, 30 days

Current-quarter EPS estimate

$0.000

90d

$0.000

60d

$0.000

30d

$0.010

−$0.060

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.06	-$0.06–-$0.06	—	$92.3M
Next Q	-$0.08	-$0.08–-$0.08	+52.9%	$84.0M
Current FY	-$0.28	-$0.28–-$0.28	+24.3%	$356.4M
Next FY	-$0.16	-$0.16–-$0.16	+38.5%	$372.6M